Nanobiotix S.A.

Over the last 90 days, Nanobiotix S.A. (NNBXF) shows zero detected cyber incidents and zero red-flag 8-K filings—a clean near-term operational surface. However, a quiet quarterly window does not eliminate structural or equity risks; the company operates in capital-intensive biotech with inherent financing and dilution pressures. The full $49 Report extends analysis to 12 months of SEC filings, calculates dilution risk scores, maps financing history, and flags AI-detected anomalies in officer activity and debt covenants. The full $49 Report adds equity dilution modeling, 12-month 8-K context, and machine-flagged anomaly signals that a 90-day snapshot cannot capture.